Effects of hemodialysis on serum lipids and phospholipids of end-stage renal failure patients

By Piperi C.   Kalofoutis C.   Tzivras M.   Troupis T.   Skenderis A.   Kalofoutis A.  

Molecular and Cellular Biochemistry, Vol. 265, Iss. 1-2, 2004-10 ,pp. : 57-61

Springer Publishing Company

Access to resources Recommend Favorite

Treating anemia in heart failure patients: a review of erythropoiesis-stimulating agents

By Geisler Benjamin P  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 8, 2010-08 ,pp. : 1209-1216

Informa Healthcare

Access to resources Recommend Favorite

Apolipoprotein D as a novel marker in human end-stage heart failure: a preliminary study

By Wei Ying-Jie   Huang Yin-Xia   Zhang Xiao-Ling   Li Jun   Huang Jie   Zhang Hao   Hu Sheng-Shou  

Biomarkers, Vol. 13, Iss. 5, 2008-08 ,pp. : 535-548

Informa Healthcare

Access to resources Recommend Favorite

Bone marrow-derived mononuclear cell therapy for patients with ischemic heart disease and ischemic heart failure

By Wen Yanting   Chen Bing   Wang Chen   Ma Xiaodong   Gao Qian  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 12, 2012-12 ,pp. : 1563-1573

Informa Healthcare

Access to resources Recommend Favorite

New York Heart Association class versus amino-terminal pro-B type natriuretic peptide for acute heart failure prognosis

By Baggish Aaron L.   van Kimmenade Roland R. J.   Pinto Yigal   Richards A. Mark   Lainchbury John   Bayes-Genis Antoni   Santaló Miquel   Ordonez-Llanos Jordi   Januzzi James L.  

Biomarkers, Vol. 15, Iss. 4, 2010-06 ,pp. : 307-314

Informa Healthcare

Access to resources Recommend Favorite